4//SEC Filing
Romano Kelly A 4
Accession 0001415889-24-018177
CIK 0001620463other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 7:21 PM ET
Size
7.1 KB
Accession
0001415889-24-018177
Insider Transaction Report
Form 4
Romano Kelly A
Director
Transactions
- Purchase
Common Stock
2024-06-21$2.26/sh+15,000$33,872→ 53,315 total - Purchase
Common Stock
2024-06-24$2.42/sh+27,400$66,179→ 80,715 total
Footnotes (2)
- [F1]The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.20 to $2.32, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.
- [F2]The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.39 to $2.43, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.
Documents
Issuer
Athira Pharma, Inc.
CIK 0001620463
Entity typeother
Related Parties
1- filerCIK 0001722055
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 7:21 PM ET
- Size
- 7.1 KB